TWST: Twist Bioscience Corporation Stock

by  •  • Comments Off on TWST: Twist Bioscience Corporation Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 2,733.04
Enterprise Value ($M) 2,506.72
Book Value ($M) 472.69
Book Value / Share 7.93
Price / Book 5.78
NCAV ($M) 205.14
NCAV / Share 3.44
Price / NCAV 13.32

Profitability (mra)
Return on Invested Capital (ROIC) -0.37
Return on Assets (ROA) -0.28
Return on Equity (ROE) -0.35

Liquidity (mrq)
Quick Ratio 4.54
Current Ratio 4.88

Balance Sheet (mrq) ($M)
Current Assets 346.78
Assets 614.32
Liabilities 141.63
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 312.97
Operating Income -175.90
Net Income -208.73
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -64.09
Cash from Investing -3.07
Cash from Financing 6.89

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-08 13G Invesco Ltd. 6.30
11-08 13G/A Nikko Asset Management Americas, Inc. 4.88 -20.16
11-05 13G/A Sumitomo Mitsui Trust Holdings, Inc. 4.88 -20.16
08-09 13G/A Jpmorgan Chase & Co 4.30 -43.77
07-09 13G/A Artisan Partners Limited Partnership 10.40 62.99
02-13 13G/A Vanguard Group Inc 9.49 -3.90
02-12 13G William Blair Investment Management, Llc 6.20
02-09 13G/A Fmr Llc 0.53 -90.04
01-29 13G/A ARK Investment Management LLC 12.51 7.65
01-25 13G/A State Street Corp 5.83 -24.04
01-24 13G/A BlackRock, Inc. 10.30 -4.29
01-22 13G/A Integrated Core Strategies (us) Llc 3.20 -40.21

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-08-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-17 109,103 517,942 21.06
2025-01-16 95,321 541,780 17.59
2025-01-15 95,939 645,906 14.85
2025-01-14 101,199 560,469 18.06
2025-01-13 58,158 381,914 15.23

(click for more detail)

Similar Companies
TRML – Tourmaline Bio, Inc. TSHA – Taysha Gene Therapies, Inc.
TSVT – 2seventy bio, Inc. TXMD – TherapeuticsMD, Inc.
TYRA – Tyra Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io